📊 Score Breakdown
Offering Ability
20
Cash Runway
85
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
54%
🔄 Reverse Split
70%
• 50-day avg $0.08 below $1 exchange minimum
• Only 5 months cash — financial pressure
📉 Score Deterioration
40%
• Score rose 26 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 5 months remaining
💹 Market Data
Market Cap$5.34M
Shares Outstanding69.13M
FloatN/A
Cash$388.4K
Debt$14.5K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest20.3K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for NBLXF
📊 NBLXF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NBLXF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.